CAS: 152044-53-6; (1R,5S,6S,7R,10S,14S,16S)-6,10-Dihydroxy-5,7,9,9-Tetramethyl-14-[(E)-1-(2-Methyl-1,3-Thiazol-4-yl)Prop-1-En-2-Yl]-13,17-Dioxabicyclo[14.1.0]Heptadecane-8,12-Dione

该化合物是一种天然产品,是美花家族的成员,它们是以其强力抗沙素活动而闻名的大型环状化合物,源自甲状腺素细胞素,并展示了一种由16人组成的巨状状状环结构.蛋白酮A主要作为微囊稳定器,类似于分类物,与微囊子细胞子单元结合,从而抑制其脱聚合并扰乱癌症细胞的正常消毒过程.这一机制使它成为癌症疗法的候选对象,特别是在抗常规治疗的情况下.该化合物的特点是有机溶剂溶性相对较高,生理条件下的稳定性较强.其药理学特征包括对各种癌症细胞线的严重的细胞毒性,使其成为药物发展的一个关注对象.然而,与许多天然产品一样,其临床应用可能受到生物利用率和合成复杂性等因素的限制.

结构式图片

MSDS等安全信息

上下游产品

desoxyepothilone A (7S)-(tert-butyl-dimethyl-silanyloxy)-(11S)-hydroxy-8,8,(10R,12S)-tetramethyl-(3S)-[1-methyl-(2E)-(2-methyl-thiazol-4-yl)-vinyl]-4,17-dioxa-bicyclo[14.1.0]heptadecane-5,9-dione (1S,3S,7S,10R,11S,12S,16R)-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)-1-ethenyl]-11-hydroxy-7-(4-methoxybenzyloxy)-8,8,10,12-tetramethyl-4,17-dioxa-bicyclo[14.1.0]heptadecane-5,9-dione (4S,7R,8S,16S)-8-hydroxy-4-(4-methoxybenzyloxy)-5,5,7,9-tetramethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)-1-ethenyl]-1-oxacyclohexadec-13-en-2,6-dione desoxyepothilone A [4S-[4R*,7S*,8R*,9R*,13R*,14R*,16R*(E)]]-14-Azido-5,5,7,9-tetramethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-13-[(4-nitrobenzoyl)oxy]-4,8-bis [(triethylsilyl)oxy]-1-oxacyclohexadecane-2,6-dione

合成工艺路线路线简述

    (1E,3Z)-1-甲氧基-2-甲基-3-(三甲基硅氧基)-1,3-戊二烯置于吡啶,咪唑,2,6-二甲基吡啶,4-二甲氨基吡啶,N-碘代丁二酰亚胺,Lithium Aluminium Tetrahydride,草酰氯,偶氮二异丁腈,Camphor-10-Sulfonic Acid,Diethylzinc,三正丁基氢锡,二甲基二环氧乙烷,四氯化钛,Potassium Carbonate,戴斯-马丁氧化剂,对甲苯磺酸,氟化氢吡啶,二甲基亚砜,三乙胺,9-硼双环[3.3.1]壬烷,2,3-二氯-5,6-二氰基-1,4-苯醌,[双(三氟乙酰氧基)碘]苯,Lithium Diisopropyl Amide体系中,用 四氢呋喃,1,4-二氧六环,甲醇,乙醚,二氯甲烷,水,N,N-二甲基甲酰胺,丙酮,甲苯,苯 用作溶剂,化学反应 36.33H,反应生成西洛他唑
    参考文献:Total Syntheses Of Epothilones A And B
    标题:Total Syntheses Of Epothilones A And B
    摘要:Convergent,Stereocontrolled Total Syntheses Of The Microtubule-Stabilizing Macrolides Epothilones A (2) And B (3) Have Been Achieved. Four Distinct Ring-Forming Strategies Were Pursued (See Scheme 1). Of These Four,Three Were Reduced To Practice. In One Approach,The Action Of A Base On A Substance Possessing An Acetate Ester And A Nonenolizable Aldehyde Brought About A Remarkably Effective Macroaldolization See (89--> 90 + 91; 99--> 100 + 101),Simultaneously Creating The C2-C3 Bond And The Hydroxyl-Bearing Stereocenter At C-3. Alternatively,The 16-Membered Macrolide Of The Epothilones Could Be Fashioned Through A C12-C13 Ring-Closing Olefin Metathesis (E.G. See 111--> 90 + 117; 122--> 105 + 123) And Through Macrolactonization Of The Appropriate Hydroxy Acid (E.G. See 88--> 93). The Application Of A Stereospecific B-Alkyl Suzuki Coupling Strategy Permitted The Establishment Of A Cis C12-C13 Olefin,Thus Setting The Stage For An Eventual Site-And Diastereoselective Epoxidation Reaction (See 96--> 2; 106--> 3). The Development Of A Novel Cyclopropane Solvolysis Strategy For Incorporating The Geminal Methyl Groups Of The Epothilones (See 39--> 40--> 41),And The Use Of Lewis Acid Catalyzed Diene-Aldehyde Cyclocondensation (Lacdac) (See 35 + 36--> 37) And Asymmetric Allylation (See 10--> 76) Methodology Are Also Noteworthy.
    Doi:10.1021/ja971946K

    海关参考信息

    专利信息


    专利号:US-2004018598-A1
    优先权日:2000-05-30
    标题 :Bio-intermediates for use in the chemical synthesis of polyketides
    发明人:SANTI DANIEL; ASHLEY GARY; MYLES DAVID C
    摘要:The present invention relates to compounds made by a subset of modules from one or more polyketide synthase (“PKSâ€?) genes that are used as starting material in the chemical synthesis of novel molecules, particularly naturally occurring polyketides or derivatives thereof. The biologically derived intermediates (“bio-intermediatesâ€?) generally represent particularly difficult compounds to synthesize using traditional chemical approaches due to one or more stereocenters. In one aspect of the invention, an intermediate in the synthesis of epothilone is provided that feeds into the synthetic protocol of Danishefsky and co-workers. In another aspect of the invention, intermediates in the synthesis of discodermolide are provided that feed into the synthetic protocol of Smith and co-workers. By taking advantage of the inherent stereochemical specificity of biological processes, the syntheses of key intermediates and thus the overall syntheses of compounds like epothilone and discodermolide are greaty simplified.

    专利号:WO-2005054429-A3
    优先权日:2003-11-19
    标 题:Synthesis of the c1-c6 keto-acid synthon of the epothilones
    发明人:AVERY MITCHELL A; ZHENG YANSONG
    权利人:UNIV MISSISSIPPI; AVERY MITCHELL A; ZHENG YANSONG
    摘要:The present invention relates to alternative methods for producing keto-acid synthons, which are useful for the synthesis of epothilones and analogs and derivatives thereof. A general method according to the present invention broadly comprises performing aldol condensation of a first aldehyde of a general formula: (I) with a carbonyl compound in the form of a ketone or a second aldehyde having a generalized formula: (II) thereby to form a first compound having a generalized formula : (III) and thereafter converting the first compound to a protected keto-`acid synthon of generalized formula: (IV) The present invention is also directed to chemical compounds useful in the synthesis of epothilones and analogs and derivatives thereof and to methods for forming each of these chemical compounds.

    专利号:US-6350878-B1
    优先权日:1998-05-18
    标 题 :Intermediates for the synthesis of epothilones and methods for their preparation
    发明人:ALTMANN KARL-HEINZ; BAUER ARMIN; SCHINZER DIETER
    权利人:NOVARTIS AG
    摘要:The invention relates to a method of synthesis for a compound of formula (I),wherein R is a heterocyclyl moiety and X1, X2, X3 and X4 are, independently of each other, protecting groups, which is appropriate for the synthesis of epothilone B and desoxyepothione B.

    专利号:US-2007015260-A1
    优先权日:2002-03-14
    标 题:Synthesis of synthons for the manufacture of bioactive compounds
    发明人:WONG CHI-HUEY; LIU JUNJIE; DESANTIS GRACE; BURK MARK
    权利人:SCRIPPS RESEARCH INST
    摘要:The present invention is based on the discovery that 2-deoxyribose-5-phosphate aldolase (DERA, EC 4.1.2.4) and variants thereof can be used to catalyze sequential asymmetric aldol reactions between a wide variety of donor and acceptor aldehydes. The reaction products typically contain at least two new stereogenic centers and can be produced in enantiomerically pure form. As such, DERA catalyzed asymmetric aldol chemistry can be exploited to produce synthons for the synthesis of a variety of bioactive molecules.

    专利号:US-6933385-B2
    优先权日:2001-08-03
    标题 :Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
    发明人:WESTERMANN JURGEN; PLATZEK JOHANNES; PETROV ORLIN
    权利人:SCHERING AG
    摘要:The invention relates to new protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use of the new compounds for the production of epothilones or epothilone derivatives.

    专利号:US-6603015-B2
    优先权日:1999-03-29
    标题:Synthesis of epothilones
    发明人:GEORG GUNDA I; NAIR SAJIV K; REIFF EMILY; TUNOORI ASHOK RAO
    权利人:UNIV KANSAS
    摘要:Commercially feasible methods for synthesizing various epothilones precursors needed for the preparation of final epothilones are provided, including techniques for the synthesis of epothilone segment A and C precursors. Segment C precursors are prepared using starting nitriles, which can alternately be oxidized to ketones and converted, or reacted to form the diol with subsequent conversion to the segment. Segment A precursors are prepared by reacting a starting enone with a chiral catalyst to give an intermediate alcohol in high enantomeric excess, followed by conversion of the alcohol to the desired Segment A precursor.
    湖北宏中药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hcpharm.com
    电话: 027-8765-9162👤
    📞湖北宏中药业股份有限公司 ⚠️参考联系方式

    销售电话:027-8765-9162
    邮箱:sales@hcpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Altmann KH. Epothilone B and its analogs - a new family of anticancer agents. Mini Rev Med Chem. 2003 Mar;3(2):149-58. doi: 10.2174/1389557033405269. 145(5):1726-1742. doi: 10.1093/brain/awac079.
    3: Parajuli P, Pandey RP, Koirala N, Yoon YJ, Kim BG, Sohng JK. Enzymatic synthesis of epothilone A glycosides. AMB Express. 2014 Mar 20;4:31. doi: 10.1186/s13568-014-0031-1.
    4: Pandey RP, Dhakal D, Thapa SB, Bashyal P, Kim TS, Sohng JK. UPLC-PDA coupled HR-TOF ESI/MS2 -based identification of derivatives produced by whole-cell biotransformation of epothilone A using Nocardia sp. CS692 and a cytochrome P450 overexpressing strain. Biotechnol Appl Biochem. 2022 Aug;69(4):1723-1732. doi: 10.1002/bab.2241. Epub 2021 Sep 2. 33(2):137-46. doi: 10.1007/s10719-015-9646-y. Epub 2016 Feb 6.

    合成参考文献


    参考文献:10.1007/s12094-010-0474-z
    摘要:Gutiérrez-Gutiérrez G, Sereno M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clinical and Translational Oncology. 2010 Feb 20;12(2):81–91. doi: 10.1007/s12094-010-0474-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知